Comparison of Quality of Life in Patients With Epilepsy Taking Zonisamide or Topiramate: Before and After Treatment.
- Author:
Hyung Ki HONG
1
;
Ji Eun KIM
;
Jang Joon LEE
;
Se Jin LEE
;
Sung Pa PARK
;
Sang Doe YI
Author Information
1. Department of Neurology, Catholic University of Daegu School of Medicine, Daegu, Korea. jekim2@cu.ac.kr
- Publication Type:Original Article
- Keywords:
Quality of life;
Epilepsy;
QOLIE-31;
Antiepileptic drug
- MeSH:
Cohort Studies;
Epilepsy;
Humans;
Isoxazoles;
Male;
Prospective Studies;
Quality of Life;
Surveys and Questionnaires;
Seizures
- From:Journal of the Korean Neurological Association
2011;29(3):172-176
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Patients with epilepsy experience impairments in their quality of life (QOL). The objective of this study was to determine the influences of clinical factors on QOL and to compare QOL before and after antiepileptic drug (AED) treatment. METHODS: A cohort of 79 patients with epilepsy (43 male and 36 female) was recruited for this prospective study. The Quality of Life in Epilepsy (QOLIE)-31 survey was applied to evaluate QOL. The QOLIE-31 questionnaire was completed by the subjects before and 24 weeks after AED monotherapy (zonisamide or topiramate). The relationships of demographic, social, and clinical factors with QOL were evaluated. RESULTS: There was a negative correlation between seizure frequency and QOL in patients with epilepsy (p<0.05). The scores of patients without adverse effect were significantly higher for the seizure worry item of the QOLIE-31 questionnaire at 24 weeks compared to baseline (p<0.05). No other significant differences were found for any of the other QOLIE-31 items. CONCLUSIONS: Age, sex, seizure frequency, AED treatment, and AED adverse effects were significant clinical factors affecting QOL in patients with epilepsy. It is suggested that the physician should recognize these factors and manage them appropriately to improve the QOL of patients with epilepsy.
